– USA, MA – Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified biopharmaceutical company, announced the appointment of the current Lead Independent Director, Gino Santini, as the next Chairman of its Board of Directors at the AGM on May 15, 2025, to succeed founder Mike Heffernan who will retire from the Board.…
– USA, PA – Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis, today announced it has appointed Dr.…
– USA, NC – Parexel, one of the world’s largest clinical research organizations providing the full range of Phase I to IV clinical development services, announced the appointment of Jeff Bernstein to its Board of Directors effective March 5, 2025, succeeding Michael Bruun as part of a planned rotation.…
– USA, FL – AIM ImmunoTech Inc. (NYSE American: AIM) announced the appointment of David Chemerow to its Board as an Independent Director, effective immediately, bringing more than 40 years of finance, accounting, and operations leadership experience across multiple industries.…
– USA, NJ – Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, announced the appointments of Dr.…